跳至主要内容
临床试验/NCT00212381
NCT00212381已完成3 期

Diindolylmethane (DIM) Dietary Supplementation: A Nonsurgical Treatment for Cervical Intraepithelial Neoplasia (CIN)

New York Presbyterian Hospital1 个研究点 分布在 1 个国家目标入组 62 人开始时间: 2000年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
62
试验地点
1
主要终点
Measure the regression of CIN in women by cytology, colposcopy, and biopsy,

研究概览

简要总结

To determine if the use of oral Diindolylmethante (DIM), a marketed cruciferous vegetable based dietary supplement (Bioresponse-DIM), is associated with the regression of cervical dysplasia in otherwise healthy women.

详细描述

To determine if the use of oral Diindolylmethane (DIM), a marketed cruciferous vegetable based dietary supplement (BioResponse-DIM®), is associated with the regression of cervical dysplasia in otherwise healthy women. Additionally, the study aims to see how the use of the BioResponse-DIM supplement correlates with cervical HPV colonization, and to asses the tolerability of daily DIM supplementation

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

central pharmacy dispenses based on sealed randomization table

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Non pregnant women greater than or equal to 18 years of age able to consent
  • CIN II or III confirmed by histology
  • Karnofsky performance status >= 80
  • No prior treatment for dysplasia in the past 4 months

排除标准

  • Incompletely visible lesion
  • Diethylstilbestrol (DES) exposure
  • HIV seropositive

研究组 & 干预措施

oral DIM (Active agent)

Experimental

2mg/kg/day po of DIM

干预措施: di indolylmethane (DIM) (Drug)

Red rice bran (Placebo)

Active Comparator

this agent is not generally thought to be active but may be

干预措施: Red rice bran (Dietary Supplement)

结局指标

主要结局

Measure the regression of CIN in women by cytology, colposcopy, and biopsy,

时间窗: 3 months

To determine if oral DIM is effective in promoting the regression of CIN in women

次要结局

  • Adverse events reported by subjects and lab abnormalities i.e. CBC and SMA20(one year)
  • HPV colonization by commercial ELIZA test(3 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Giuseppe Del Priore

Professor

New York Presbyterian Hospital

研究点 (1)

Loading locations...

相似试验